BMRN
Price
$63.30
Change
+$0.56 (+0.89%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
12.03B
6 days until earnings call
CLNN
Price
$2.97
Change
-$0.20 (-6.31%)
Updated
Apr 25, 04:59 PM (EDT)
Capitalization
27.36M
Ad is loading...

BMRN vs CLNN

Header iconBMRN vs CLNN Comparison
Open Charts BMRN vs CLNNBanner chart's image
BioMarin Pharmaceutical
Price$63.30
Change+$0.56 (+0.89%)
Volume$8.98K
Capitalization12.03B
Clene
Price$2.97
Change-$0.20 (-6.31%)
Volume$600
Capitalization27.36M
BMRN vs CLNN Comparison Chart
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. CLNN commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a StrongBuy and CLNN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (BMRN: $62.74 vs. CLNN: $3.17)
Brand notoriety: BMRN and CLNN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 51% vs. CLNN: 737%
Market capitalization -- BMRN: $12.03B vs. CLNN: $27.36M
BMRN [@Biotechnology] is valued at $12.03B. CLNN’s [@Biotechnology] market capitalization is $27.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileCLNN’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • CLNN’s FA Score: 0 green, 5 red.
According to our system of comparison, both BMRN and CLNN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 5 TA indicator(s) are bullish while CLNN’s TA Score has 5 bullish TA indicator(s).

  • BMRN’s TA Score: 5 bullish, 5 bearish.
  • CLNN’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CLNN is a better buy in the short-term than BMRN.

Price Growth

BMRN (@Biotechnology) experienced а +6.03% price change this week, while CLNN (@Biotechnology) price change was +5.67% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.17%. For the same industry, the average monthly price growth was -4.24%, and the average quarterly price growth was -12.55%.

Reported Earning Dates

BMRN is expected to report earnings on Aug 05, 2025.

CLNN is expected to report earnings on Mar 24, 2025.

Industries' Descriptions

@Biotechnology (+7.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($12B) has a higher market cap than CLNN($27.4M). BMRN YTD gains are higher at: -4.549 vs. CLNN (-40.301). BMRN has higher annual earnings (EBITDA): 651M vs. CLNN (-29.61M). BMRN has more cash in the bank: 1.14B vs. CLNN (14.6M). CLNN has less debt than BMRN: CLNN (22.9M) vs BMRN (603M). BMRN has higher revenues than CLNN: BMRN (2.85B) vs CLNN (421K).
BMRNCLNNBMRN / CLNN
Capitalization12B27.4M43,796%
EBITDA651M-29.61M-2,198%
Gain YTD-4.549-40.30111%
P/E Ratio28.39N/A-
Revenue2.85B421K677,910%
Total Cash1.14B14.6M7,795%
Total Debt603M22.9M2,633%
FUNDAMENTALS RATINGS
BMRN vs CLNN: Fundamental Ratings
BMRN
CLNN
OUTLOOK RATING
1..100
1375
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7799
PRICE GROWTH RATING
1..100
7693
P/E GROWTH RATING
1..100
9895
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRN's Valuation (68) in the Biotechnology industry is in the same range as CLNN (84) in the null industry. This means that BMRN’s stock grew similarly to CLNN’s over the last 12 months.

BMRN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as CLNN (100) in the null industry. This means that BMRN’s stock grew similarly to CLNN’s over the last 12 months.

BMRN's SMR Rating (77) in the Biotechnology industry is in the same range as CLNN (99) in the null industry. This means that BMRN’s stock grew similarly to CLNN’s over the last 12 months.

BMRN's Price Growth Rating (76) in the Biotechnology industry is in the same range as CLNN (93) in the null industry. This means that BMRN’s stock grew similarly to CLNN’s over the last 12 months.

CLNN's P/E Growth Rating (95) in the null industry is in the same range as BMRN (98) in the Biotechnology industry. This means that CLNN’s stock grew similarly to BMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNCLNN
RSI
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
64%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
67%
Bullish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
61%
Bullish Trend 17 days ago
79%
Declines
ODDS (%)
Bearish Trend 18 days ago
60%
Bearish Trend 3 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
56%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CLNN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RENT4.300.30
+7.50%
Rent the Runway
TXG8.310.30
+3.68%
10x Genomics
CMRE9.170.30
+3.38%
Costamare
RCL211.313.81
+1.84%
Royal Caribbean Group
NXDT3.64-0.02
-0.55%
NexPoint Diversified Real Estate Trust

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with IBO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then IBO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
+1.29%
IBO - BMRN
45%
Loosely correlated
-0.19%
SRPT - BMRN
45%
Loosely correlated
+3.82%
IONS - BMRN
42%
Loosely correlated
+1.62%
ITOS - BMRN
42%
Loosely correlated
+4.34%
AXON - BMRN
42%
Loosely correlated
+2.39%
More

CLNN and

Correlation & Price change

A.I.dvisor tells us that CLNN and KZIA have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CLNN and KZIA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLNN
1D Price
Change %
CLNN100%
+12.01%
KZIA - CLNN
33%
Poorly correlated
+2.78%
GOSS - CLNN
30%
Poorly correlated
+9.43%
BMRN - CLNN
29%
Poorly correlated
+1.29%
QNCX - CLNN
29%
Poorly correlated
+6.13%
VRNA - CLNN
28%
Poorly correlated
+2.32%
More